Affimed N.V. Competitors and Similar CompaniesClear all
Affimed N.V.'s competitors and similar companies include Skyepharma and BTG.
 Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. | |||
Founding Date | Founding Date 2000 | Founding Date 1996 | Founding Date 1948 |
Type | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations Heidelberg, DE HQ | Locations Saint-Quentin-Fallavier, FR HQ | |
Employees | Employees 76 | Employees 2453% increase | Employees 650 |
Financial | |||
Revenue (est.) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods N/A | Cost of goods £43.1m (FY, 2015) | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit €13m (FY, 2023) | Gross profit £52.8m (FY, 2015) | Gross profit £510.3m (FY, 2019) |
Net income | Net income (€105.9m) (FY, 2023) | Net income N/A | Net income £88.3m (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Skyepharma
HQ
Saint-Quentin-Fallavier, FR
Skyepharma is a drug delivery company developing oral and inhalation products.
View company